Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NITE

Nightstar Therapeutics (NITE) Stock Price, News & Analysis

Nightstar Therapeutics logo

About Nightstar Therapeutics Stock (NASDAQ:NITE)

Key Stats

Today's Range
$35.37
$35.96
50-Day Range
$25.41
$25.41
52-Week Range
$9.59
$29.55
Volume
3,046 shs
Average Volume
185,808 shs
Market Capitalization
$1.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NITE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nightstar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NITE Stock News Headlines

Urgent Buy Alert: My Top Three Quantum Computing Stocks
Quantum computing is the hottest tech trend of the year... With some of these stocks jumping 700%, 2,800% and even 4,000% over the past 12 months alone. But please, do NOT buy the most popular quantum stocks out there... They're trading at ridiculous valuations and could lead to huge losses down the road.tc pixel
Knight Therapeutics price target lowered to C$6.25 from C$6.75 at Stifel
NITE The Nightview ETF
Thank you for supporting The Big Night In
See More Headlines

NITE Stock Analysis - Frequently Asked Questions

Nightstar Therapeutics PLC (NASDAQ:NITE) issued its quarterly earnings results on Tuesday, November, 13th. The company reported ($0.27) earnings per share for the quarter, topping analysts' consensus estimates of ($0.40) by $0.13.

Nightstar Therapeutics (NITE) raised $76 million in an initial public offering (IPO) on Thursday, September 28th 2017. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO and Wedbush PacGrow and Chardan were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nightstar Therapeutics investors own include Canopy Growth (CGC), Cronos Group (CRON), OncoMed Pharmaceuticals (OMED), Portola Pharmaceuticals (PTLA), Ligand Pharmaceuticals (LGND), Neurocrine Biosciences (NBIX) and Sangamo Therapeutics (SGMO).

Company Calendar

Last Earnings
11/13/2018
Today
10/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NITE
CIK
1711675
Fax
N/A
Employees
47
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$36.86 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-30.89%
Return on Assets
-27.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.54
Quick Ratio
8.54

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.89 per share
Price / Book
6.11

Miscellaneous

Outstanding Shares
33,540,000
Free Float
N/A
Market Cap
$1.21 billion
Optionable
Not Optionable
Beta
2.84
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:NITE) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners